0.21 USD
▼-0.01-2.62%
盘后 0.23 0.00%
2026-09-16
市值
$6.45M
市盈率
—
EPS
-2.14
股息率
—
52 周区间
0.19 – 2.89
成交量
2.34M
Beta
1.19
目标价
4.25
52W 低 0.1952W 高 2.89
价格走势
公司简介
AIM ImmunoTech Inc., an immuno-pharma company, engages in the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company’s flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated, multi-species alpha interferon product for the treatment of genital warts. It is also ...